Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma

Journal of Urology

Volumn 155, Issue 2, 1996, Pages 459-465

  Ruiz Cerdá, José L ^b   Hernández, Miguel ^b   Gomis, Federico ^b   Vera, Cesar D ^b   Kimler, Bruce F ^b   O'Connor, J Enrique ^b   Jiménez Cruz, Fernando ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b NONE

Author keywords

carcinoma, renal cell; flow cytometry; kidney; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030020949     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66418-8     Document Type: Article

References (26)

1. Bauer, K. D., Duque, R. E. and Shankey, T. V.: Clinical Flow Cytometry: Principles and Applications. Baltimore: Williams & Wilkins, p. 1, 1993.
2. Shankey, T. V.: Urological cancers. In: Clinical Flow Cytometry: Principles and Applications. Edited by K. D. Bauer, R. E. Duque and T. V. Shankey. Baltimore: Williams & Wilkins, pp. 271-305, 1993.
3. Tosi, P., Luzi, P., Baak, J. P. A., Miracco, C., Santopietro, R., Vindigni, C., Mattei, F. M., Acconcia, A. and Massai, M. R.: Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer, 58: 2512, 1986.
4. Murphy, G. F., Partin, A. W., Maygarden, S. J. and Mohler, J. L.: Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. J. Urol., 143: 1103, 1990.
5. Gutierrez, J. L., Val-Bernal, J. F., Garijo, M. F., Buelta, L. and Portillo, J. A.: Nuclear morphometry in prognosis of renal adenocarcinoma. Urology, 39: 130, 1992.
6. Fuhrman, S. A., Lasky, L. C. and Limas, C.: Prognostic significance of morphologic parameters in renal cell carcinoma. Amer. J. Surg. Path., 6: 655, 1982.
7. Hedley, D. W., Friedlander, M. L. and Taylor, I. W.: Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry, 6: 327, 1985.
8. Vindeløv, L. L.: Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch. Cell Path., 24: 227, 1977.
9. Ljungberg, B., Stenling, R. and Roos, G.: DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer, 56: 503, 1985.
10. Grignon, D. J., Ayala, A. G., El-Naggar, A., Wishnow, K. I., Ro, J. Y., Swanson, D. A., McLemore, D., Giacco, G. G. and Guinee, V. F.: Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Cancer, 64: 2133, 1989.
11. Currin, S. M., Lee, S. E. and Walther, P. J.: Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone? J. Urol., 143: 458, 1990.
12. Lanigan, D., McLean, P. A., Murphy, D. M., Donovan, M. G., Curran, B. and Leader, M.: Ploidy and prognosis in renal carcinoma. Brit. J. Urol., 71: 21, 1993.
13. Rainwater, L. M., Hosaka, Y., Farrow, G. M. and Lieber, M. M.: Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry. J. Urol., 137: 15, 1987.
14. Banner, B. F., Ernstoff, M. S., Bahnson, R. R., Titus-Ernstoff, L. and Taylor, S. R.: Quantitative DNA analysis of small renal cortical neoplasms. Hum. Path., 22: 247, 1991.
15. Raviv, G., Leibovich, I., Mor, Y., Nass, D., Medalia, O., Goldwasser, B. and Nativ, O.: Localized renal cell carcinoma treated by radical nephrectomy. Influence of pathologic data and the importance of DNA ploidy pattern on disease outcome. Cancer, 72: 2207, 1993.
16. Nakano, E., Kondoh, M., Okatani, K., Seguchi, T. and Sugao, H.: Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features. Cancer, 72: 1319, 1993.
17. Grignon, D. J., el-Naggar, A., Green, L. K., Ayala, A. G., Ro, J. Y., Swanson, D. A., Troncoso, P., McLemore, D., Giacco, G. G. and Guinee, V. F.: DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma. Cancer, 63: 1161, 1989.
18. Ljungberg, B., Larsson, P., Stenling, R. and Roos, G.: Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma. J. Urol., 146: 697, 1991.
19. Chin, J. L., Pontes, J. E. and Frankfurt, O. S.: Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J. Urol., 133: 582, 1985.
20. Bibbo, M., Galera-Davidson, H., Dytch, H. E., Gonzalez de Chaves, J., Lopez-Garrido, J., Bartels, P. H. and Wied, G. L.: Karyometry and histometry of renal-cell carcinoma. Anal. Quant. Cytol. Histol., 9: 182, 1987.
21. Eskelinen, M., Lipponen, P., Aitto-Oja, L., Hall, O. and Syrjänen, K.: The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma. Int. J. Cancer, 55: 547, 1993.
22. Pound, C. R., Partin, A. W., Epstein, J. I., Simons, J. W. and Marshall, F. F.: Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology, 42: 243, 1993.
23. González-Cámpora, R., González de Chaves, F. J., Mora-Marin, J., Rodriguez-González, R., Utrilla-Alcolea, J. C., Rubí-Uría, J. and Galera-Davidson, H.: Nuclear planimetry in renal-cell tumors. Anal. Quant. Cytol. Histol., 13: 54, 1991.
24. Artacho-Pérula, E., Roldán-Villalobos, R. and Martínez-Cuevas, J. F.: Value of volume weighted mean nuclear volume in grading and prognosis of renal cell carcinoma. J. Clin. Path., 47: 324, 1994.
25. Donhuijsen, K., Schulz, S. and Leder, L. D.: Nuclear grading of renal cell carcinomas - is morphometry necessary? J. Cancer Res. Clin. Oncol., 117: 73, 1991.
26. Thrasher, J. B. and Paulson, D. F.: Prognostic factors in renal cancer. Urol. Clin. N. Amer., 20: 247, 1993.